Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insmed Incorporated - Common Stock (NQ:INSM)

126.05 +2.06 (+1.67%)
Streaming Delayed Price Updated: 11:20 AM EDT, Aug 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 334,011
Open 124.65
Bid (Size) 125.93 (100)
Ask (Size) 126.16 (200)
Prev. Close 123.98
Today's Range 124.30 - 127.18
52wk Range 90.39 - 212.75
Shares Outstanding 115,246,666
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Insmed (INSM) Q2 2026 Earnings Call Transcript ↗
BRINSUPRI revenue surged to $309.2 million, driving total revenues to $425.5 million. 
Via The Motley Fool
Topics Earnings
News headline image
$1000 Invested In Insmed 5 Years Ago Would Be Worth This Much Today ↗
Insmed (NASDAQ:INSM) has outperformed the market over the past 5 years by 29.76% on an annualized basis producing an average annual return of 41.43%. Currently, Insmed has a market capitalization of... 
Via Benzinga

Performance

YTD
-28.8%
-28.8%
1 Month
+20.4%
+20.4%
3 Month
+15.8%
+15.8%
6 Month
-20.7%
-20.7%
1 Year
-1.8%
-1.8%

More News

Read More
News headline image
Insmed Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Insmed (NASDAQ:INSM) Q1 Revenue Miss Triggers Pre-Market Slide Despite Narrower Loss ↗
Via Chartmill
Which stocks are moving before the opening bell on Thursday? ↗
Via Chartmill
News headline image
What Happens to Stocks After Joining the Nasdaq-100 (History Has a Clear Answer) ↗
Via The Motley Fool
Topics Artificial Intelligence Electric Vehicles Initial Public Offering
News headline image
Insmed's TPIP Shows Durable PAH Benefits in 12-Month Study ↗
Via MarketBeat
Monday's after hours session: top gainers and losers ↗
Via Chartmill
Tuesday's after hours session: top gainers and losers ↗
Via Chartmill
News headline image
NWI Management Dumps 42,700 MercadoLibre Shares Worth $82.4 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More ↗
Via The Motley Fool
News headline image
Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus ↗
Via MarketBeat
News headline image
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares ↗
Via The Motley Fool
News headline image
This Nuclear Tech Stock Grew Revenue 27%, But a Fund Still Slashed Its Stake ↗
Via The Motley Fool
Topics Energy Regulatory Compliance
News headline image
This Retail Stock Is Down 10% in a Year Despite Record Revenue. A Fund Just Cut Its Stake ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Trade School Stock Is Up 135%. Here’s Why a Fund Still Bought 459,000 Shares ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Callaway Stock Has Soared 150%. Here’s Why One Fund Still Bought 1.1 Million Shares ↗
Via The Motley Fool
News headline image
Insmed (INSM) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year ↗
Via The Motley Fool

Frequently Asked Questions

Is Insmed Incorporated - Common Stock publicly traded?
Yes, Insmed Incorporated - Common Stock is publicly traded.
What exchange does Insmed Incorporated - Common Stock trade on?
Insmed Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Insmed Incorporated - Common Stock?
The ticker symbol for Insmed Incorporated - Common Stock is INSM on the Nasdaq Stock Market
What is the current price of Insmed Incorporated - Common Stock?
The current price of Insmed Incorporated - Common Stock is 126.05
When was Insmed Incorporated - Common Stock last traded?
The last trade of Insmed Incorporated - Common Stock was at 08/25/26 11:20 AM ET
What is the market capitalization of Insmed Incorporated - Common Stock?
The market capitalization of Insmed Incorporated - Common Stock is 14.53B
How many shares of Insmed Incorporated - Common Stock are outstanding?
Insmed Incorporated - Common Stock has 15B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.